Ensign Peak Advisors Inc cut its stake in Encompass Health Co. (NYSE:EHC) by 0.8% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 89,957 shares of the company’s stock after selling 725 shares during the period. Ensign Peak Advisors Inc’s holdings in Encompass Health were worth $7,019,000 at the end of the most recent quarter.
A number of other large investors also recently added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its holdings in Encompass Health by 1.4% in the second quarter. Vanguard Group Inc. now owns 9,310,952 shares of the company’s stock valued at $726,533,000 after purchasing an additional 126,115 shares during the period. Schroder Investment Management Group boosted its holdings in Encompass Health by 12.9% in the first quarter. Schroder Investment Management Group now owns 1,251,115 shares of the company’s stock valued at $102,467,000 after purchasing an additional 142,797 shares during the period. Geode Capital Management LLC lifted its holdings in Encompass Health by 1.3% during the 2nd quarter. Geode Capital Management LLC now owns 1,190,604 shares of the company’s stock worth $92,902,000 after buying an additional 14,701 shares during the last quarter. Bank of Montreal Can lifted its holdings in Encompass Health by 9.9% during the 2nd quarter. Bank of Montreal Can now owns 820,583 shares of the company’s stock worth $64,661,000 after buying an additional 73,675 shares during the last quarter. Finally, Principal Financial Group Inc. lifted its holdings in Encompass Health by 9.9% during the 1st quarter. Principal Financial Group Inc. now owns 780,559 shares of the company’s stock worth $63,928,000 after buying an additional 70,509 shares during the last quarter. Hedge funds and other institutional investors own 90.64% of the company’s stock.
A number of analysts have issued reports on the company. Raymond James raised Encompass Health from an “outperform” rating to a “strong-buy” rating and lifted their price target for the stock from $95.00 to $107.00 in a report on Monday, August 2nd. UBS Group assumed coverage on Encompass Health in a report on Thursday, September 23rd. They set a “buy” rating and a $98.00 price target for the company. Credit Suisse Group lifted their price target on Encompass Health from $96.00 to $98.00 and gave the stock an “outperform” rating in a report on Thursday, July 29th. Truist cut their target price on Encompass Health from $100.00 to $88.00 and set a “buy” rating on the stock in a research report on Wednesday. Finally, Royal Bank of Canada lifted their target price on Encompass Health from $102.00 to $104.00 and gave the stock an “outperform” rating in a research report on Thursday, July 29th. One research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $96.70.
Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Monday, July 26th. The company reported $1.17 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.98 by $0.19. The firm had revenue of $1.29 billion for the quarter, compared to analysts’ expectations of $1.28 billion. Encompass Health had a return on equity of 19.49% and a net margin of 7.83%. The firm’s revenue for the quarter was up 22.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.34 EPS. Analysts expect that Encompass Health Co. will post 4.43 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 15th. Investors of record on Friday, October 1st will be given a $0.28 dividend. This represents a $1.12 annualized dividend and a yield of 1.67%. The ex-dividend date is Thursday, September 30th. Encompass Health’s dividend payout ratio (DPR) is presently 38.75%.
Encompass Health Profile
Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provides rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations.
Read More: What is the Federal Reserve?
Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHC).
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.